- Home
- EVR vs BAX Comparison
EVR vs BAX Comparison
Compare EVR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVR
- BAX
- Stock Information
- Founded
- EVR 1995
- BAX 1931
- Country
- EVR United States
- BAX United States
- Employees
- EVR N/A
- BAX N/A
- Industry
- EVR Investment Managers
- BAX Medical/Dental Instruments
- Sector
- EVR Finance
- BAX Health Care
- Exchange
- EVR Nasdaq
- BAX Nasdaq
- Market Cap
- EVR 11.6B
- BAX 11.3B
- IPO Year
- EVR 2006
- BAX N/A
- Fundamental
- Price
- EVR $320.40
- BAX $22.72
- Analyst Decision
- EVR Buy
- BAX Hold
- Analyst Count
- EVR 9
- BAX 9
- Target Price
- EVR $324.22
- BAX $30.78
- AVG Volume (30 Days)
- EVR 464.3K
- BAX 6.1M
- Earning Date
- EVR 10-22-2025
- BAX 11-07-2025
- Dividend Yield
- EVR 1.05%
- BAX 2.98%
- EPS Growth
- EVR 52.07
- BAX N/A
- EPS
- EVR 11.01
- BAX N/A
- Revenue
- EVR $3,238,871,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- EVR $19.32
- BAX $7.39
- Revenue Next Year
- EVR $22.67
- BAX $3.79
- P/E Ratio
- EVR $29.05
- BAX N/A
- Revenue Growth
- EVR 23.41
- BAX 3.60
- 52 Week Low
- EVR $148.63
- BAX $21.33
- 52 Week High
- EVR $364.42
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- EVR 45.67
- BAX 45.76
- Support Level
- EVR $300.72
- BAX $21.88
- Resistance Level
- EVR $339.04
- BAX $23.04
- Average True Range (ATR)
- EVR 10.79
- BAX 0.68
- MACD
- EVR -2.88
- BAX 0.05
- Stochastic Oscillator
- EVR 41.15
- BAX 41.18
About EVR Evercore Inc.
Evercore Inc is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.